vs

Side-by-side financial comparison of Consensus Cloud Solutions, Inc. (CCSI) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

Consensus Cloud Solutions, Inc. is the larger business by last-quarter revenue ($88.5M vs $44.6M, roughly 2.0× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Consensus Cloud Solutions, Inc. runs the higher net margin — 27.9% vs -90.4%, a 118.3% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 1.5%). Consensus Cloud Solutions, Inc. produced more free cash flow last quarter ($38.5M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 0.6%).

Consensus Cloud Solutions, Inc. is a provider of cloud-based secure information delivery and digital workflow solutions. Its core offerings include encrypted digital fax, secure document exchange, and process automation tools, serving clients across healthcare, legal, financial services and enterprise sectors, with a primary operating market in North America.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

CCSI vs PACB — Head-to-Head

Bigger by revenue
CCSI
CCSI
2.0× larger
CCSI
$88.5M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+12.3% gap
PACB
13.8%
1.5%
CCSI
Higher net margin
CCSI
CCSI
118.3% more per $
CCSI
27.9%
-90.4%
PACB
More free cash flow
CCSI
CCSI
$58.4M more FCF
CCSI
$38.5M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
0.6%
CCSI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CCSI
CCSI
PACB
PACB
Revenue
$88.5M
$44.6M
Net Profit
$24.7M
$-40.4M
Gross Margin
80.9%
37.1%
Operating Margin
42.7%
-92.3%
Net Margin
27.9%
-90.4%
Revenue YoY
1.5%
13.8%
Net Profit YoY
16.7%
-1802.7%
EPS (diluted)
$1.30
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCSI
CCSI
PACB
PACB
Q1 26
$88.5M
Q4 25
$87.1M
$44.6M
Q3 25
$87.8M
$38.4M
Q2 25
$87.7M
$39.8M
Q1 25
$87.1M
$37.2M
Q4 24
$87.0M
$39.2M
Q3 24
$87.8M
$40.0M
Q2 24
$87.5M
$36.0M
Net Profit
CCSI
CCSI
PACB
PACB
Q1 26
$24.7M
Q4 25
$20.5M
$-40.4M
Q3 25
$22.1M
$-38.0M
Q2 25
$20.8M
$-41.9M
Q1 25
$21.2M
$-426.1M
Q4 24
$18.1M
$2.4M
Q3 24
$21.1M
$-60.7M
Q2 24
$23.9M
$-173.3M
Gross Margin
CCSI
CCSI
PACB
PACB
Q1 26
80.9%
Q4 25
80.0%
37.1%
Q3 25
80.0%
41.4%
Q2 25
79.9%
36.9%
Q1 25
79.3%
-3.7%
Q4 24
79.5%
25.6%
Q3 24
79.9%
25.0%
Q2 24
80.4%
16.5%
Operating Margin
CCSI
CCSI
PACB
PACB
Q1 26
42.7%
Q4 25
41.1%
-92.3%
Q3 25
43.2%
-101.1%
Q2 25
44.5%
-112.8%
Q1 25
43.0%
-1154.5%
Q4 24
38.4%
-390.1%
Q3 24
43.8%
-160.3%
Q2 24
45.6%
-488.3%
Net Margin
CCSI
CCSI
PACB
PACB
Q1 26
27.9%
Q4 25
23.5%
-90.4%
Q3 25
25.2%
-98.9%
Q2 25
23.7%
-105.4%
Q1 25
24.3%
-1146.8%
Q4 24
20.8%
6.0%
Q3 24
24.1%
-151.9%
Q2 24
27.3%
-481.3%
EPS (diluted)
CCSI
CCSI
PACB
PACB
Q1 26
$1.30
Q4 25
$1.06
$-0.11
Q3 25
$1.15
$-0.13
Q2 25
$1.07
$-0.14
Q1 25
$1.07
$-1.44
Q4 24
$0.92
$-0.44
Q3 24
$1.09
$-0.22
Q2 24
$1.24
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCSI
CCSI
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$92.3M
$279.5M
Total DebtLower is stronger
$556.8M
Stockholders' EquityBook value
$22.0M
$5.3M
Total Assets
$678.7M
$784.1M
Debt / EquityLower = less leverage
25.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCSI
CCSI
PACB
PACB
Q1 26
$92.3M
Q4 25
$74.7M
$279.5M
Q3 25
$97.6M
$298.7M
Q2 25
$57.9M
$314.7M
Q1 25
$53.4M
$343.1M
Q4 24
$33.5M
$389.9M
Q3 24
$54.6M
$471.1M
Q2 24
$49.2M
$509.8M
Total Debt
CCSI
CCSI
PACB
PACB
Q1 26
$556.8M
Q4 25
$558.4M
Q3 25
$578.6M
Q2 25
$578.2M
Q1 25
$583.7M
Q4 24
$593.0M
Q3 24
$612.5M
Q2 24
$642.8M
Stockholders' Equity
CCSI
CCSI
PACB
PACB
Q1 26
$22.0M
Q4 25
$13.8M
$5.3M
Q3 25
$-2.6M
$36.1M
Q2 25
$-26.5M
$61.5M
Q1 25
$-49.4M
$91.6M
Q4 24
$-79.5M
$506.6M
Q3 24
$-93.2M
$453.1M
Q2 24
$-124.4M
$492.7M
Total Assets
CCSI
CCSI
PACB
PACB
Q1 26
$678.7M
Q4 25
$663.8M
$784.1M
Q3 25
$675.0M
$803.2M
Q2 25
$641.5M
$825.5M
Q1 25
$629.6M
$860.8M
Q4 24
$602.2M
$1.3B
Q3 24
$622.5M
$1.5B
Q2 24
$608.5M
$1.5B
Debt / Equity
CCSI
CCSI
PACB
PACB
Q1 26
25.31×
Q4 25
40.54×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCSI
CCSI
PACB
PACB
Operating Cash FlowLast quarter
$45.8M
$-19.1M
Free Cash FlowOCF − Capex
$38.5M
$-19.9M
FCF MarginFCF / Revenue
43.5%
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
1.86×
TTM Free Cash FlowTrailing 4 quarters
$110.6M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCSI
CCSI
PACB
PACB
Q1 26
$45.8M
Q4 25
$15.2M
$-19.1M
Q3 25
$51.6M
$-18.7M
Q2 25
$28.3M
$-29.4M
Q1 25
$40.9M
$-44.1M
Q4 24
$11.1M
$-30.6M
Q3 24
$41.6M
$-45.5M
Q2 24
$24.4M
$-54.3M
Free Cash Flow
CCSI
CCSI
PACB
PACB
Q1 26
$38.5M
Q4 25
$7.3M
$-19.9M
Q3 25
$44.4M
$-18.8M
Q2 25
$20.3M
$-29.9M
Q1 25
$33.7M
$-45.4M
Q4 24
$3.1M
$-32.3M
Q3 24
$33.6M
$-46.3M
Q2 24
$15.8M
$-55.7M
FCF Margin
CCSI
CCSI
PACB
PACB
Q1 26
43.5%
Q4 25
8.4%
-44.6%
Q3 25
50.6%
-48.9%
Q2 25
23.2%
-75.3%
Q1 25
38.7%
-122.3%
Q4 24
3.6%
-82.3%
Q3 24
38.3%
-115.7%
Q2 24
18.1%
-154.8%
Capex Intensity
CCSI
CCSI
PACB
PACB
Q1 26
Q4 25
9.1%
1.9%
Q3 25
8.2%
0.2%
Q2 25
9.1%
1.4%
Q1 25
8.3%
3.7%
Q4 24
9.2%
4.1%
Q3 24
9.1%
2.0%
Q2 24
9.8%
4.1%
Cash Conversion
CCSI
CCSI
PACB
PACB
Q1 26
1.86×
Q4 25
0.74×
Q3 25
2.34×
Q2 25
1.36×
Q1 25
1.94×
Q4 24
0.62×
-12.93×
Q3 24
1.97×
Q2 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCSI
CCSI

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons